Evelyn M. Horn
Expertise in
14
conditions

Dr. Evelyn M. Horn

Advanced Heart Failure and Transplant Cardiology | Cardiology
Weill Medical College Of Cornell
520 E 70th St, 
New York, NY 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
Expertise in
14
conditions
Weill Medical College Of Cornell
520 E 70th St, 
New York, NY 

Overview

Evelyn Horn is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in New York, New York. Dr. Horn is highly rated in 14 conditions, according to our data. Her top areas of expertise are Pulmonary Hypertension, Hypertension, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Transplant, and Aortic Valve Replacement.

Her clinical research consists of co-authoring 124 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Advanced Heart Failure and Transplant Cardiology
Cardiology

Licenses

Internal Medicine in NY

Hospital Affiliations

New York-Presbyterian Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health First
  • HMO
  • POS
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
Northwell Health
  • INSURANCE PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

WEILL MEDICAL COLLEGE OF CORNELL
520 E 70th St, New York, NY 10021

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Tricuspid Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System and Optimal Medical Therapy (OMT) Compared to OMT Alone in Patients With Tricuspid Regurgitation
A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Tricuspid Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System and Optimal Medical Therapy (OMT) Compared to OMT Alone in Patients With Tricuspid Regurgitation
Enrollment Status: Recruiting
Publish Date: January 21, 2026
Intervention Type: Device, Drug
Study Phase: Not Applicable
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Completed
Publish Date: February 06, 2026
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Terminated
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Completed
Publish Date: June 10, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device Implantation
A Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device Implantation
Enrollment Status: Completed
Publish Date: March 30, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug, Biological
Study Drug: Sotatercept
Study Phase: Phase 3
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by CPET in Subjects With WHO Group 1 Pulmonary Hypertension Who Recently Initiated Therapy
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by CPET in Subjects With WHO Group 1 Pulmonary Hypertension Who Recently Initiated Therapy
Enrollment Status: Terminated
Publish Date: October 24, 2023
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
Clinical Study of the BioVentrix Revivent TC™ System for Treatment of Left Ventricular Aneurysms (ALIVE)
Clinical Study of the BioVentrix Revivent TC™ System for Treatment of Left Ventricular Aneurysms (ALIVE)
Enrollment Status: Active_not_recruiting
Publish Date: August 22, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Enrollment Status: Completed
Publish Date: February 21, 2023
Intervention Type: Other, Biological, Drug, Diagnostic test
Study Phase: Phase 2
Sensible Medical Innovations (Noninvasive) Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients- a Randomized Controlled Study
Sensible Medical Innovations (Noninvasive) Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients- a Randomized Controlled Study
Enrollment Status: Terminated
Publish Date: December 29, 2017
Intervention Type: Device
Study Phase: Not Applicable
Percutaneous Ventricular Restoration in Chronic Heart Failure Due to Ischemic Heart Disease
Percutaneous Ventricular Restoration in Chronic Heart Failure Due to Ischemic Heart Disease
Enrollment Status: Terminated
Publish Date: June 23, 2017
Intervention Type: Device
Study Phase: Phase 3
View 10 Less Clinical Trials

124 Total Publications

Prevalence and Clinical Implications of Excess Adiposity in Group 1 Pulmonary Hypertension.
Prevalence and Clinical Implications of Excess Adiposity in Group 1 Pulmonary Hypertension.
Journal: Circulation. Heart failure
Published: December 03, 2025
Similar Doctors
Nir Y. Uriel
Expertise in
14
conditions
Dr. Nir Y. Uriel
Advanced Heart Failure and Transplant Cardiology | Cardiology
Expertise in
14
conditions
Dr. Nir Y. Uriel
Advanced Heart Failure and Transplant Cardiology | Cardiology

Trustees Of Columbia University In The City Of New York

622 W 168th St, 
New York, NY 
 (5.3 miles away)
212-305-9876
Languages Spoken:
English
See accepted insurances

Nir Uriel is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in New York, New York. Dr. Uriel is highly rated in 14 conditions, according to our data. His top areas of expertise are Heart Failure, Cardiogenic Shock, Heart Attack, Heart Transplant, and Heart Bypass Surgery.

Expertise in
11
conditions
Dr. Parag Goyal
Advanced Heart Failure and Transplant Cardiology | Cardiology
Expertise in
11
conditions
Dr. Parag Goyal
Advanced Heart Failure and Transplant Cardiology | Cardiology

Weill Medical College Of Cornell

1305 York Ave, 
New York, NY 
 (0.1 miles away)
212-590-5723
Languages Spoken:
English
See accepted insurances

Parag Goyal is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in New York, New York. Dr. Goyal is highly rated in 11 conditions, according to our data. His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, COVID-19, Cardiac Ablation, and Transcatheter Aortic Valve Replacement (TAVR).

Sean P. Pinney
Expertise in
8
conditions
Dr. Sean P. Pinney
Advanced Heart Failure and Transplant Cardiology | Cardiology
Expertise in
8
conditions
Dr. Sean P. Pinney
Advanced Heart Failure and Transplant Cardiology | Cardiology

Icahn School Of Medicine At Mount Sinai

1 Gustave L Levy Pl, 
New York, NY 
 (1.8 miles away)
212-731-7822
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Sean Pinney is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in New York, New York. Dr. Pinney is highly rated in 8 conditions, according to our data. His top areas of expertise are Heart Failure, Pulmonary Edema, Cardiogenic Shock, Heart Transplant, and Endoscopy. Dr. Pinney is currently accepting new patients.

Frequently Asked Questions about Dr. Evelyn M. Horn

How do I make an appointment with Dr. Evelyn M. Horn?

You can book an appointment with Dr. Evelyn M. Horn by calling their office at 212-746-2150. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Evelyn M. Horn a top-rated expert for Pulmonary Hypertension?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Evelyn M. Horn is classified as an Elite expert for Pulmonary Hypertension, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Evelyn M. Horn specialize in?

While Dr. Evelyn M. Horn is a Advanced Heart Failure and Transplant Cardiology, they have specific expertise in Pulmonary Hypertension, Hypertension, and Heart Failure with Preserved Ejection Fraction (HFpEF). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Advanced Heart Failure and Transplant Cardiology.

Does Dr. Evelyn M. Horn participate in research or clinical trials?

Yes. Dr. Evelyn M. Horn has published 124 articles and abstracts on conditions like Pulmonary Hypertension. You can view a list of Dr. Evelyn M. Horn's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Evelyn M. Horn accept my insurance?

Dr. Evelyn M. Horn accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 212-746-2150 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Horn's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 39 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile